PubRank

Gianluca Severi

Author PubWeight™ 234.67‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Multiple newly identified loci associated with prostate cancer susceptibility. Nat Genet 2008 15.43
2 Large-scale genotyping identifies 41 new loci associated with breast cancer risk. Nat Genet 2013 8.24
3 Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2. Nat Genet 2009 7.30
4 A genome-wide association study identifies colorectal cancer susceptibility loci on chromosomes 10p14 and 8q23.3. Nat Genet 2008 6.26
5 Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics. PLoS Genet 2008 6.22
6 Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 cases from 12 studies. PLoS Med 2010 6.04
7 Identification of seven new prostate cancer susceptibility loci through a genome-wide association study. Nat Genet 2009 6.04
8 Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array. Nat Genet 2013 5.58
9 A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population. Nat Genet 2010 4.96
10 Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies. J Natl Cancer Inst 2010 4.54
11 A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2. Nat Genet 2009 4.38
12 Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nat Genet 2013 4.35
13 Multiple loci on 8q24 associated with prostate cancer susceptibility. Nat Genet 2009 3.94
14 Genome-wide association studies identify four ER negative-specific breast cancer risk loci. Nat Genet 2013 3.81
15 Detectable clonal mosaicism and its relationship to aging and cancer. Nat Genet 2012 3.69
16 GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer. Nat Genet 2013 3.42
17 A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancer. Nat Genet 2011 3.37
18 Genome-wide association analysis identifies three new breast cancer susceptibility loci. Nat Genet 2012 3.20
19 Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study. Nat Genet 2011 3.07
20 Multiple novel prostate cancer predisposition loci confirmed by an international study: the PRACTICAL Consortium. Cancer Epidemiol Biomarkers Prev 2008 3.05
21 Risk of estrogen receptor-positive and -negative breast cancer and single-nucleotide polymorphism 2q35-rs13387042. J Natl Cancer Inst 2009 2.88
22 Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium. Hum Mol Genet 2011 2.72
23 Tyrol Prostate Cancer Demonstration Project: early detection, treatment, outcome, incidence and mortality. BJU Int 2008 2.60
24 Genome-wide association study identifies new prostate cancer susceptibility loci. Hum Mol Genet 2011 2.51
25 A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11. Hum Mol Genet 2012 2.45
26 Insulin-like growth factors, their binding proteins, and prostate cancer risk: analysis of individual patient data from 12 prospective studies. Ann Intern Med 2008 2.33
27 Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers. Am J Hum Genet 2013 2.24
28 HOXB13 is a susceptibility gene for prostate cancer: results from the International Consortium for Prostate Cancer Genetics (ICPCG). Hum Genet 2012 2.18
29 Genome-wide association study of glioma and meta-analysis. Hum Genet 2012 1.96
30 Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia. Nat Genet 2013 1.85
31 19p13.1 is a triple-negative-specific breast cancer susceptibility locus. Cancer Res 2012 1.81
32 Fine-mapping identifies multiple prostate cancer risk loci at 5p15, one of which associates with TERT expression. Hum Mol Genet 2013 1.78
33 Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer. Nat Commun 2013 1.73
34 A multicentre epidemiological study on sunbed use and cutaneous melanoma in Europe. Eur J Cancer 2005 1.70
35 Common breast cancer susceptibility loci are associated with triple-negative breast cancer. Cancer Res 2011 1.65
36 Association of ESR1 gene tagging SNPs with breast cancer risk. Hum Mol Genet 2009 1.58
37 A risk prediction algorithm based on family history and common genetic variants: application to prostate cancer with potential clinical impact. Genet Epidemiol 2011 1.58
38 Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium. Hum Mol Genet 2011 1.56
39 Evidence of gene-environment interactions between common breast cancer susceptibility loci and established environmental risk factors. PLoS Genet 2013 1.56
40 Assessing interactions between the associations of common genetic susceptibility variants, reproductive history and body mass index with breast cancer risk in the breast cancer association consortium: a combined case-control study. Breast Cancer Res 2010 1.51
41 A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease. Hum Mol Genet 2012 1.47
42 Characterizing associations and SNP-environment interactions for GWAS-identified prostate cancer risk markers--results from BPC3. PLoS One 2011 1.41
43 Refinement of the basis and impact of common 11q23.1 variation to the risk of developing colorectal cancer. Hum Mol Genet 2008 1.40
44 Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1. Am J Hum Genet 2013 1.39
45 Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31. Nat Commun 2013 1.36
46 Androgenetic alopecia and prostate cancer: findings from an Australian case-control study. Cancer Epidemiol Biomarkers Prev 2002 1.30
47 Common genetic variants in prostate cancer risk prediction--results from the NCI Breast and Prostate Cancer Cohort Consortium (BPC3). Cancer Epidemiol Biomarkers Prev 2012 1.29
48 Five polymorphisms and breast cancer risk: results from the Breast Cancer Association Consortium. Cancer Epidemiol Biomarkers Prev 2009 1.29
49 CHEK2*1100delC heterozygosity in women with breast cancer associated with early death, breast cancer-specific death, and increased risk of a second breast cancer. J Clin Oncol 2012 1.29
50 Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer. Carcinogenesis 2013 1.28
51 11q13 is a susceptibility locus for hormone receptor positive breast cancer. Hum Mutat 2012 1.26
52 Confirmation of 5p12 as a susceptibility locus for progesterone-receptor-positive, lower grade breast cancer. Cancer Epidemiol Biomarkers Prev 2011 1.23
53 The role of genetic breast cancer susceptibility variants as prognostic factors. Hum Mol Genet 2012 1.23
54 Compelling evidence for a prostate cancer gene at 22q12.3 by the International Consortium for Prostate Cancer Genetics. Hum Mol Genet 2007 1.20
55 Cyclin D1 splice variants: polymorphism, risk, and isoform-specific regulation in prostate cancer. Clin Cancer Res 2009 1.17
56 Association between a germline OCA2 polymorphism at chromosome 15q13.1 and estrogen receptor-negative breast cancer survival. J Natl Cancer Inst 2010 1.17
57 Body size, weight change, and risk of colon cancer. Cancer Epidemiol Biomarkers Prev 2010 1.16
58 Comparison of 6q25 breast cancer hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC). PLoS One 2012 1.13
59 Circulating steroid hormone levels and risk of breast cancer for postmenopausal women. Cancer Epidemiol Biomarkers Prev 2010 1.12
60 The use of DNA from archival dried blood spots with the Infinium HumanMethylation450 array. BMC Biotechnol 2013 1.09
61 Circulating 25-hydroxyvitamin D3 in relation to renal cell carcinoma incidence and survival in the EPIC cohort. Am J Epidemiol 2014 1.09
62 Foods, nutrients and prostate cancer. Cancer Causes Control 2004 1.09
63 Measures of familial aggregation depend on definition of family history: meta-analysis for colorectal cancer. J Clin Epidemiol 2006 1.08
64 Prostate cancer segregation analyses using 4390 families from UK and Australian population-based studies. Genet Epidemiol 2010 1.04
65 The E211 G>A androgen receptor polymorphism is associated with a decreased risk of metastatic prostate cancer and androgenetic alopecia. Cancer Epidemiol Biomarkers Prev 2005 1.04
66 Weight change and prostate cancer incidence and mortality. Int J Cancer 2012 1.03
67 The epidemiology of prostate cancer. Urol Clin North Am 2003 1.02
68 Prediagnosis biomarkers of insulin-like growth factor-1, insulin, and interleukin-6 dysregulation and multiple myeloma risk in the Multiple Myeloma Cohort Consortium. Blood 2012 1.01
69 Psychological and clinical factors implicated in decision making about a trial of low-dose tamoxifen in hormone replacement therapy users. J Clin Oncol 2008 1.01
70 A large-scale assessment of two-way SNP interactions in breast cancer susceptibility using 46,450 cases and 42,461 controls from the breast cancer association consortium. Hum Mol Genet 2013 1.00
71 Early growth, adult body size and prostate cancer risk. Int J Cancer 2003 0.99
72 Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA. Hum Genet 2013 0.99
73 Number and size of nevi are influenced by different sun exposure components: implications for the etiology of cutaneous melanoma (Belgium, Germany, France, Italy). Cancer Causes Control 2003 0.97
74 Validation of prostate cancer risk-related loci identified from genome-wide association studies using family-based association analysis: evidence from the International Consortium for Prostate Cancer Genetics (ICPCG). Hum Genet 2011 0.97
75 A phase II study of topotecan with vincristine and doxorubicin in children with recurrent/refractory neuroblastoma. Cancer 2003 0.96
76 9q31.2-rs865686 as a susceptibility locus for estrogen receptor-positive breast cancer: evidence from the Breast Cancer Association Consortium. Cancer Epidemiol Biomarkers Prev 2012 0.95
77 Second to fourth digit ratio (2D:4D) and concentrations of circulating sex hormones in adulthood. Reprod Biol Endocrinol 2011 0.94
78 Association analysis of 9,560 prostate cancer cases from the International Consortium of Prostate Cancer Genetics confirms the role of reported prostate cancer associated SNPs for familial disease. Hum Genet 2013 0.93
79 Plasma phospholipid fatty acids, dietary fatty acids and prostate cancer risk. Int J Cancer 2013 0.93
80 Dental amalgam and mercury levels in autopsy tissues: food for thought. Am J Forensic Med Pathol 2006 0.93
81 Population-based estimate of prostate cancer risk for carriers of the HOXB13 missense mutation G84E. PLoS One 2013 0.93
82 Dietary patterns and prostate cancer risk. Cancer Epidemiol Biomarkers Prev 2009 0.91
83 5alpha-Reductase type 2 gene variant associations with prostate cancer risk, circulating hormone levels and androgenetic alopecia. Int J Cancer 2007 0.91
84 Missense variants in ATM in 26,101 breast cancer cases and 29,842 controls. Cancer Epidemiol Biomarkers Prev 2010 0.91
85 The rs12975333 variant in the miR-125a and breast cancer risk in Germany, Italy, Australia and Spain. J Med Genet 2011 0.91
86 Re: Prospective studies of dairy product and calcium intakes and prostate cancer risk: a meta-analysis. J Natl Cancer Inst 2006 0.91
87 Interleukin-6 promoter variants, prostate cancer risk, and survival. Prostate 2012 0.90
88 Alcohol consumption and risk of glioblastoma; evidence from the Melbourne Collaborative Cohort Study. Int J Cancer 2011 0.90
89 Risk of ovarian cancer and the NF-κB pathway: genetic association with IL1A and TNFSF10. Cancer Res 2013 0.89
90 Atypia and Ki-67 expression from ductal lavage in women at different risk for breast cancer. Cancer Epidemiol Biomarkers Prev 2006 0.88
91 Genome-wide linkage analysis of 1,233 prostate cancer pedigrees from the International Consortium for Prostate Cancer Genetics using novel sumLINK and sumLOD analyses. Prostate 2010 0.88
92 Genetic variants in the vitamin D receptor gene and prostate cancer risk. Cancer Epidemiol Biomarkers Prev 2005 0.88
93 Screening for prostate cancer: updated experience from the Tyrol study. Can J Urol 2005 0.88
94 Oral lichen planus: mercury and its kin. Arch Dermatol 2005 0.87
95 Methylmercury, amalgams, and children's health. Environ Health Perspect 2006 0.87
96 Identification of new genetic susceptibility loci for breast cancer through consideration of gene-environment interactions. Genet Epidemiol 2013 0.86
97 Association between adult height, genetic susceptibility and risk of glioma. Int J Epidemiol 2012 0.86
98 Sex differences in numbers of nevi on body sites of young European children: implications for the etiology of cutaneous melanoma. Cancer Epidemiol Biomarkers Prev 2004 0.86
99 Macrophage inhibitory cytokine-1 H6D polymorphism, prostate cancer risk, and survival. Cancer Epidemiol Biomarkers Prev 2006 0.85
100 Dietary intake of B vitamins and methionine and breast cancer risk. Cancer Causes Control 2013 0.85
101 Alcohol consumption and prostate cancer risk: results from the Melbourne collaborative cohort study. Int J Cancer 2006 0.85
102 A novel polymorphism in a forkhead box A1 (FOXA1) binding site of the human UDP glucuronosyltransferase 2B17 gene modulates promoter activity and is associated with altered levels of circulating androstane-3α,17β-diol glucuronide. Mol Pharmacol 2010 0.85
103 Dietary intake of B vitamins and methionine and prostate cancer incidence and mortality. Cancer Causes Control 2012 0.85
104 Identification of new genetic risk factors for prostate cancer. Asian J Androl 2008 0.85
105 Analysis of irradiated lung and heart volumes using virtual simulation in postoperative treatment of stage I breast carcinoma. Tumori 2003 0.84
106 A whole of population-based series of radical prostatectomy in Victoria, 1995 to 2000. Aust N Z J Public Health 2009 0.84
107 Anthropometric measures and bladder cancer risk: a prospective study in the EPIC cohort. Int J Cancer 2014 0.84
108 Macrophage scavenger receptor 1 999C>T (R293X) mutation and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 2005 0.83
109 Genetic modifiers of menopausal hormone replacement therapy and breast cancer risk: a genome-wide interaction study. Endocr Relat Cancer 2013 0.83
110 A breast cancer screening programme operating in a liberal health care system: the Luxembourg Mammography Programme, 1992-1997. Int J Cancer 2002 0.83
111 Interactions between genome-wide significant genetic variants and circulating concentrations of insulin-like growth factor 1, sex hormones, and binding proteins in relation to prostate cancer risk in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium. Am J Epidemiol 2012 0.82
112 Chromosomes 4 and 8 implicated in a genome wide SNP linkage scan of 762 prostate cancer families collected by the ICPCG. Prostate 2011 0.81
113 Dietary intake of B vitamins and methionine and colorectal cancer risk. Nutr Cancer 2013 0.81
114 Age-dependent associations between androgenetic alopecia and prostate cancer risk. Cancer Epidemiol Biomarkers Prev 2012 0.81
115 Rural residency and prostate cancer specific mortality: results from the Victorian Radical Prostatectomy Register. Aust N Z J Public Health 2014 0.80
116 Frequency of ejaculation and risk of prostate cancer. JAMA 2004 0.80
117 Breast cancer risk and 6q22.33: combined results from Breast Cancer Association Consortium and Consortium of Investigators on Modifiers of BRCA1/2. PLoS One 2012 0.80
118 7q21-rs6964587 and breast cancer risk: an extended case-control study by the Breast Cancer Association Consortium. J Med Genet 2011 0.80
119 Dental amalgam, mercury toxicity, and renal autoimmunity. J Environ Pathol Toxicol Oncol 2008 0.79
120 No association between common chemokine and chemokine receptor gene variants and prostate cancer risk. Cancer Epidemiol Biomarkers Prev 2008 0.79
121 Variation at ABO histo-blood group and FUT loci and diffuse and intestinal gastric cancer risk in a European population. Int J Cancer 2014 0.79
122 Detection of infectious organisms in archival prostate cancer tissues. BMC Cancer 2014 0.79
123 Confirmation of the reduction of hormone replacement therapy-related breast cancer risk for carriers of the HSD17B1_937_G variant. Breast Cancer Res Treat 2013 0.78
124 Additive interactions between susceptibility single-nucleotide polymorphisms identified in genome-wide association studies and breast cancer risk factors in the Breast and Prostate Cancer Cohort Consortium. Am J Epidemiol 2014 0.78
125 Common genetic variants associated with disease from genome-wide association studies are mutually exclusive in prostate cancer and rheumatoid arthritis. BJU Int 2012 0.77
126 Inflammatory Cytokines and Lung Cancer Risk in 3 Prospective Studies. Am J Epidemiol 2016 0.76
127 Mercury in amalgam tattoos. Micron 2007 0.76
128 Analysis of Xq27-28 linkage in the international consortium for prostate cancer genetics (ICPCG) families. BMC Med Genet 2012 0.76
129 The postmenopausal hormone replacement therapy-related breast cancer risk is decreased in women carrying the CYP2C19*17 variant. Breast Cancer Res Treat 2011 0.76
130 Anthropometry and the Risk of Lung Cancer in EPIC. Am J Epidemiol 2016 0.76
131 A case control study investigating the effects of levels of physical activity at work as a risk factor for prostate cancer. Environ Health 2014 0.76
132 Re: Sun exposure and mortality from melanoma. J Natl Cancer Inst 2005 0.76
133 Five genetic variants associated with prostate cancer. N Engl J Med 2008 0.76
134 The 4q27 locus and prostate cancer risk. BMC Cancer 2010 0.76
135 Corrigendum: Genome-wide association study of colorectal cancer identifies six new susceptibility loci. Nat Commun 2015 0.76
136 Correction: vitamin d metabolic pathway genes and pancreatic cancer risk. PLoS One 2015 0.75
137 Sarcoidosis. N Engl J Med 2008 0.75
138 Metals, orthopaedic implants, and risk of cancer. Lancet 2007 0.75
139 Oral cancer: an association with dental metal restorations and allergy to metals? Int J Dermatol 2007 0.75
140 Correlating blood mercury and dental amalgams. Sci Total Environ 2007 0.75
141 Ultraviolet B sensitivity of peripheral lymphocytes as an independent risk factor for cutaneous melanoma. Eur J Cancer 2005 0.75
142 Screening for prostate cancer: updated experience from the Tyrol study. Curr Urol Rep 2004 0.75
143 Primary therapy with ECF in combination with a GnRH analog in premenopausal women with hormone receptor-positive T2-T4 breast cancer. Breast 2006 0.75
144 No strong association between second to fourth digit ratio (2D:4D) and adult anthropometric measures with emphasis on adiposity. Ann Hum Biol 2012 0.75
145 Association of DNA Methylation-Based Biological Age with Health Risk Factors, and Overall and Cause-Specific Mortality. Am J Epidemiol 2017 0.75